New Ottawa Hospital–based network will focus on improving the quality of life of Canadians
December 15, 2014 – Ottawa – Industry Canada
Royal Galipeau, Member of Parliament for Ottawa–Orléans, today announced that BioCanRX, one of four new Networks of Centres of Excellence, is receiving $25 million over five years to support collaborative research aimed at developing novel Canadian therapies to fight against cancer.
BioCanRX will help accelerate the most promising discoveries from the lab through to proof of concept, manufacturing and clinical testing. By incorporating patient outreach into the research program, the network will help spread knowledge to end users and receive critical feedback about cancer treatment. BioCanRX will seek to make Canada more competitive in biotherapeutics and reduce the human and financial cost of cancer.
This investment is the result of the most recent competition in the Networks of Centres of Excellence (NCE) program. The competition resulted in four new networks receiving funding and one existing network being renewed for a second five-year term.
NCEs mobilize a critical mass of expertise from across the country, bringing together health, natural and social scientists, as well as engineers. Partners from industry, government and the not-for-profit sector contribute additional expertise and support.
Director of Communications and Parliamentary Affairs
Office of the Minister of State (Science and Technology)
Media and Public Affairs Officer
Natural Sciences and Engineering Research Council of Canada